Risultati di ricerca
1 giorno fa · ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
- Solutions
ICON experts can help to implement patient-centric,...
- Sectors
Sectors - ICON plc | Clinical Research Organisation (CRO)...
- Therapeutics
ICON has been recognised for having 'exceeded customer...
- Insights
Digital Disruption Technologies that accelerate and improve...
- News & Events
News & Events - ICON plc | Clinical Research Organisation...
- About ICON
About ICON - ICON plc | Clinical Research Organisation (CRO)...
- Careers
ICON offers a broad range of specialised services to assist...
- Contact
Contact - ICON plc | Clinical Research Organisation (CRO)...
- Solutions
1 giorno fa · Get a real-time ICON Public Limited Company (ICLR) stock price quote with breaking news, financials, statistics, charts and more.
- 26.67B
- 8.33B
- 714.43M
- 82.82M
4 giorni fa · See the latest Icon PLC stock price (ICLR:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
3 giorni fa · Large pharma and biotechnology companies historically use traditional CRO and FSP models to deliver their clinical programs. This model lends itself well to customers without global scale, systems, or capabilities. For mid-size pharma, however, models may evolve as the company grows.
3 giorni fa · Prism Connect. ICON's eClinical solution that unifies your clinical data. Prism Connect extracts clinical trial information directly from a site’s electronic health records (EHR). Key benefits. Cost savings. By eliminating the need to enter the same data in multiple systems, Prism Connect increases efficiency and saves cost. Process efficiencies.
2 giorni fa · Latest ICON PLC (ICLR:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
3 giorni fa · Research ICON's (Nasdaq:ICLR) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.